Get started
BBB

BCAL DIAGNOSTICS LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

BDX chart


Full chart

BDX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪37.66 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.025 AUD
Net income (FY)
‪−6.40 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
—
Beta (1Y)
0.72

About BCAL DIAGNOSTICS LIMITED


Sector
Health Services
Industry
Medical/Nursing Services
CEO
Shane Ryan
Website
bcaldiagnostics.com
Headquarters
Sydney
Founded
2010
ISIN
AU0000160921
FIGI
BBG011N6JC91
BCAL Diagnostics Ltd. develops screening tests for the early detection of breast cancer. It also associated lipids, biomarker blood test that is used for prevention, screening and monitoring. The company was founded by Jayne Shaw and Ron Philips in 2010 and is headquartered in Sydney, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BDX news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BDX is 0.110 AUD — it has increased by 4.76% in the past 24 hours. Watch BCAL DIAGNOSTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange BCAL DIAGNOSTICS LIMITED stocks are traded under the ticker BDX.
BDX stock hasn't changed in a week, the month change is a −5.98% fall, over the last year there was no change in BCAL DIAGNOSTICS LIMITED price.
BDX reached its all-time high on Jul 21, 2021 with the price of 0.275 AUD, and its all-time low was 0.050 AUD and was reached on Mar 13, 2023. View more price dynamics on BDX chart.
See other stocks reaching their highest and lowest prices.
BDX stock is 0.00% volatile and has beta coefficient of 0.72. Track BCAL DIAGNOSTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is BCAL DIAGNOSTICS LIMITED there?
Today BCAL DIAGNOSTICS LIMITED has the market capitalization of ‪37.66 M‬, it has decreased by −4.55% over the last week.
Yes, you can track BCAL DIAGNOSTICS LIMITED financials in yearly and quarterly reports right on TradingView.
BCAL DIAGNOSTICS LIMITED is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
BDX net income for the last half-year is ‪−3.99 M‬ AUD, while the previous report showed ‪−2.41 M‬ AUD of net income which accounts for −65.95% change. Track more BCAL DIAGNOSTICS LIMITED financial stats to get the full picture.
No, BDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BCAL DIAGNOSTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BCAL DIAGNOSTICS LIMITED technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BCAL DIAGNOSTICS LIMITED stock shows the neutral signal. See more of BCAL DIAGNOSTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.